This is an amended filing
GI Innovation Inc. Received USD 3.5 million milestone fee from Maruho of Japan for GI301
AI summary · Not investment advice
GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.
Commentary
AI commentary · Not investment advice
What happened
GI Innovation received a technology fee of USD 3,500,000 from Maruho of Japan. The fee is tied to a milestone: the first patient was dosed in a Phase 2 clinical trial in Japan. It is paid under a license contract the two companies signed earlier.
In the company's terms
This filing is a correction. Before the correction, the company said it expected payment within 60 days after issuing the invoice. The correction sets the actual receipt date as November 16, 2026. The materials give about KRW 4.6 billion at an exchange rate of 1,324.60 won per USD.
What changes for shareholders
For scale, the company's revenue last year was KRW 5.84 billion. The materials do not give a ratio comparing the fee with that revenue.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G